Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Reported Basic Consolidated EPS Of $-0.0401 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for the period ended 2015-12-31 was $-0.0401. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-0.0401.

EPS from continuing operations

Coming to basic EPS from continuing operations, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported $-0.0401 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-0.0401.

EPS contribution from parent

For the annual period ended 2015-12-31, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) received basic EPS of $-0.0401 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-0.0401.

Basic net EPS

For the annual period ended 2015-12-31, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported basic net EPS of $-0.04. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-0.04.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-0.0401. For the quarter ended 2015-12-31, consolidated diluted EPS was $-0.0401.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.0401 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-0.0401.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-0.04. For the quarterly period ended 2015-12-31, net diluted EPS was $-0.04.

Diluted EPS from parent

From the parent company, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) received diluted EPS of $-0.0401 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-0.0401.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) posted net basic EPS reading of $-0.04 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-0.04 was for the quarter ended 2015-12-31.

Net diluted EPS for Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for the annual period ended 2015-12-31 was $-0.04. The company also reported net diluted EPS reading of $-0.04 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 125.592 while for the quarter ended 2015-12-31 is 125.592.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 125.592 while for the quarter ended 2015-12-31 is 125.592.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 24 times, 1 visits today)